MiNK Therapeutics, Inc. Common Stock (INKT)

Typically moves ±3.97% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-11-16 APPROXIMATE

Since May 10, 2022, MiNK Therapeutics, Inc. Common Stock (INKT) has reported earnings 18 times. On average the shares move ±3.97% post-earnings, with a positive reaction 77.8% of the time. Its largest post-earnings gain was +15.45% (May 14, 2024) and its largest decline was -18.84% (May 10, 2022). The next earnings report is predicted for 2026-11-16 (approximate).

Earnings reactions

How INKT moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±3.97%

Positive %

77.8%

Negative %

22.2%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 13, 2026	☀ PRE	+0%	open_in_new
May 15, 2026	☀ PRE	-0.23%	open_in_new
Mar 31, 2026	☀ PRE	+0%	open_in_new
Dec 08, 2025	☽ POST	+8.78%	open_in_new
Aug 14, 2025	☀ PRE	-14.64%	open_in_new
May 15, 2025	☀ PRE	+0%	open_in_new
Mar 18, 2025	☀ PRE	+0%	open_in_new
Nov 14, 2024	☀ PRE	+0%	open_in_new
Aug 13, 2024	☀ PRE	+0%	open_in_new
May 14, 2024	☀ PRE	+15.45%	open_in_new
Mar 21, 2024	☀ PRE	+0%	open_in_new
Nov 09, 2023	☀ PRE	+0%	open_in_new
Aug 10, 2023	☀ PRE	+3.53%	open_in_new
May 11, 2023	☀ PRE	+2.56%	open_in_new
Mar 21, 2023	☀ PRE	+0%	open_in_new
Nov 03, 2022	☀ PRE	+0%	open_in_new
Aug 09, 2022	☀ PRE	-7.46%	open_in_new
May 10, 2022	☀ PRE	-18.84%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±3.97%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 8 →

Funds holding

$238596

Total value held

Buying

7 added · 0 reduced

Blackrock, Inc.

$156435 +115.73%

Ubs Group Ag

$57106 NEW BUY

Us Bancorp \De\

$23322 NEW BUY

Morgan Stanley

$1321 +8.65%

Barclays Plc

$281 NEW BUY

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
4	20260902	open_in_new SEC.gov
4	20260902	open_in_new SEC.gov
4	20260902	open_in_new SEC.gov
4	20260902	open_in_new SEC.gov
4	20260902	open_in_new SEC.gov
10-Q	20260813	open_in_new SEC.gov
8-K	20260813	open_in_new SEC.gov
S-8	20260813	open_in_new SEC.gov
8-K	20260623	open_in_new SEC.gov
4	20260605	open_in_new SEC.gov

Frequently asked about INKT earnings

When does MiNK Therapeutics, Inc. Common Stock report earnings next? expand_more

MiNK Therapeutics, Inc. Common Stock (INKT)'s next earnings date is approximate for 2026-11-16. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does INKT stock move after earnings? expand_more

Over 18 reports, INKT has moved an average of ±3.97% the session after earnings, closing higher 77.8% of the time.

What was INKT's biggest post-earnings move? expand_more

INKT's largest post-earnings gain on record was +15.45% on May 14, 2024, and its largest decline was -18.84% on May 10, 2022.

Where can I find MiNK Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of MiNK Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.